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Abstract
Asthma prevalence has increased over the last fifty years, but the more recent changes have not
been conclusively determined. Studies in children indicate that a plateau in the prevalence of asthma
may have been reached, but this has not yet been confirmed in adults. Epidemiological studies have
suggested that the prevalence of asthma in adults is approximately 7-10% in different parts of the
western world.
We have now performed a large-scale epidemiological evaluation of the prevalence of asthma and
respiratory symptoms in adults between the ages of 16-75 in West Sweden. Thirty thousand
randomly chosen individuals were sent a detailed questionnaire focusing on asthma and respiratory
symptoms, as well possible risk factors. Sixty-two percent of the contacted individuals responded
to the questionnaire. Asthma prevalence, defined as asthma diagnosed by a physician, was 8.3%.
Moreover, the prevalence of respiratory symptoms was lower compared to previous studies. The
most common respiratory symptom was any wheeze (16.6%) followed by sputum production
(13.3%). In comparison with studies performed 18 years ago, the prevalence of asthma has not
increased, and the prevalence of most respiratory symptoms has decreased. Therefore, our data
argues that the continued increase in asthma prevalence that has been observed over the last half
century is over.
Introduction
In terms of prevalence and morbidity, asthma has
increased in most parts of the world during the second
half of the past century [1-3]. The increase was first recog-
nised in Australia, New Zealand and in areas of the United
Kingdom (UK) and the USA, countries in which the mor-
tality in asthma also increased at the time [1,4,5]. Less
change in the prevalence, morbidity and mortality was
seen in Continental [6,7] and Eastern Europe [8]. In East-
ern Europe, different diagnostic traditions compared to
Western Europe partly explained a lower prevalence
[9,10]. During the last decades of the century a marked
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increase in asthma was also detected in developing coun-
tries [11], particularly in large cities [7,11], while the prev-
alence did not change considerably in rural areas of Africa
and China [12,13]. Recent studies, including the ISAAC III
[14], suggest that the increase in asthma among children
and adolescents has leveled off in several westernized
countries [15-17]. However, in some of these countries,
such as Germany and UK, studies also point out diverging
and opposite trends [17-19]. In contrast to children, there
are no recent published studies of the change of preva-
lence in adult asthma and symptoms common in asthma.
In Sweden the asthma prevalence increased from 2-3% in
the 1970s [20,21], to approximately 5% in the 1980s
[22,23] and to 8-10% in the mid 1990s [24-26]. The
increase was first noticed in the north of Sweden [22,27]
and was, to some extent, explained by an increase in diag-
nostic activity [28]. Notably, there still seems to be a
north-south gradient in the prevalence of asthma with a
slightly higher prevalence in the north [24]. Population
based data of asthma prevalence among adults in Sweden
has not been published for the past ten years.
In 2008, a large study focusing on asthma and allergic dis-
eases was initiated in West Sweden. The first part of the
study was a postal questionnaire survey on respiratory
symptoms and diseases, as well as allergic conditions. The
initial aim was to update the prevalence of asthma, allergy
and respiratory symptoms, which is presented here. Our
hypothesis was that the increasing trend of adult asthma
in Sweden has reached a plateau.
Materials and methods
Study area and population
The study area is the region of West Sweden (Figure 1),
with the city of Gothenburg located at the North Sea.
Gothenburg is the second largest city in Sweden and had
a population of 494 000 at the end of 2007, with more
than 700 000 when including the whole urbanised area
surrounding the city. The population of the West Gothia
region was 1 547 000 in 2007, which corresponds to
approximately 1/6 of the Swedish population. A postal
questionnaire was mailed in February of 2008 to 30 000
inhabitants in the region, aged 16-75. A random selection
of 15 000 subjects was chosen from the population living
in the urbanised area of Gothenburg and its surrounds.
Similarly a random sample of 15 000 subjects of the same
age was chosen from the rest of the West Gothia region.
The names and addresses were received from the Swedish
Population Register.
Methods
External companies administered the questionnaires with
cover letters and prepaid envelopes for returning the com-
pleted questionnaires, as well as the computerisation of
collected data. Non-responders received three reminders.
The invited individuals were also given the option to
respond over the internet.
The questionnaire included three parts. The first part was
a modified version [29] of the Swedish OLIN study ques-
tionnaire [23] that has been used in several studies in
northern Europe [24-27] and contained questions about
asthma, rhinitis, chronic bronchitis/COPD/emphysema,
respiratory symptoms, use of asthma medication and pos-
sible determinants of disease, such as smoking habits and
family history of airway diseases. The second part
included questions about occupation, airborne occupa-
tional and environmental exposures, socio-economic sta-
tus and health status. The third part consisted of the
Swedish version of the GA2LEN questionnaire, which
added detailed questions about rhinitis and eczema.
Definitions
Ever asthma
"Have you ever had asthma"; Physician-diagnosed asthma:
"Have you been diagnosed as having asthma by a doctor";
Active asthma: Reported ever asthma or physician diag-
nosed asthma and at least one out of: use of asthma med-
icine, attacks of shortness of breath, any wheeze, or
recurrent wheeze; Use of asthma medicine: "Do you cur-
rently use asthma medicine (permanently or as needed)";
Rhinitis: "Have you been diagnosed as having allergic
rhinitis/hay fever by a doctor".
Attacks of shortness of breath
"Do you presently have, or have you had in the last 10
years, asthma symptoms (intermittent breathlessness or
attacks of shortness of breath; the symptoms may exist
simultaneously with or without cough or wheezing)" and
"Have you had these symptoms within the last year".
Any wheeze
"Have you had whistling or wheezing in the chest at any
occasion during the last 12 months"; Wheezing with
breathlessness: Yes to any wheeze and "Have you been at all
breathless when you had wheezing or whistling in the
chest"; Wheezing apart from cold: Yes to any wheeze and
"Have you had this wheezing or whistling in your chest
when you have not had a cold"; Wheezing with breathless-
ness apart from cold: Yes to any wheeze and "Have you been
at all breathless when you had wheezing or whistling in
the chest" and "Have you had this wheezing or whistling
in you chest when you have not had a cold"; Recurrent
wheeze: "Do you usually have wheezing or whistling in
your chest when breathing";
Longstanding cough
"Have you had a persisting cough during the last year";
Sputum production: "Do you usually have phlegm whenRespiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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coughing or do you have phlegm in the chest which is dif-
ficult to bring up"; Chronic productive cough: Sputum pro-
duction for at least three months during two subsequent
years.
Smokers reported smoking during the year preceding the
survey; Ex-smokers reported having quit smoking at least
12 months preceding the survey; Non-smokers  reported
neither smoking nor ex-smoking.
An evaluation by telephone interviews showed no statisti-
cally significant differences regarding asthma and symp-
tom prevalence between those that responded to the
postal survey and those that did not. Furthermore, the
number of reminders sent out did not change the overall
results of the study [30].
Comparison with previously performed studies
The results of the current survey were compared with the
results from two previous studies in defined geographic
areas within the region of West Gothia. The first study, the
Gothenburg part of the European Community Respira-
tory Health Survey (ECRHS), was performed on the island
of Hisingen in the city of Gothenburg. This study was per-
formed in 1990, with 2884 participants aged 20-44 years
[31]. The second study was conducted in 1994 in a south-
ern part of the West Gothia region, the former county of
Southern Älvsborg, with 15 813 participants aged 16-50
[32]. In order to compare results, subsets of the current
study from the same areas and of the same age composi-
tions were used. These subsets in each of the two areas
consisted of 1238 and 1167 subjects respectively. The
comparisons were based on the results of identical or very
similar questions used in the comparison studies.
Ethical approval
The study was approved by the Ethics Committee at the
University of Gothenburg.
Analyses
Ten percent of the data was entered twice for quality con-
trol of the computerisation. Errors amounted to 0.1-0.2%
of the computerised data with only a few exceptions. Sta-
tistical analyses were performed using SPSS version 16.0.
Comparisons of proportions were tested with a chi-square
test or Fisher's exact test and comparisons of means were
tested with a two-tailed Student's t-test. One way analysis
of variance (ANOVA) was used for test for trends. A p-
value of < 0.05 was regarded as statistically significant.
Covariates used in the analyses included age, sex, family
history of asthma, smoking habits, area of domicile and
rhinitis. Rhinitis was used as a surrogate variable for
atopy. Multiple logistic regression models were performed
using these independent variables as risk factors (odd
ratios (OR), with 95% confidence intervals (CI)) of
asthma and respiratory symptoms.
Results
Participation and smoking
Of the 30 000 subjects randomly selected for the ques-
tionnaire, at least 782 were not traceable, resulting in an
actual study sample of 29 218 subjects, of which 18 087
(62%) participated. Only 814 subjects, 4.5% of the
responders, used the option to answer over the internet.
Female sex and domicile outside of the metropolitan area
was significantly associated with being traceable (Table
1). Women had a higher response rate (67%) compared
to men (56%, p < 0.001). There was a greater response rate
among participants living outside the metropolitan area
of Gothenburg compared to within (64% vs. 60% respec-
tively; p < 0.001). Participation increased significantly by
age (p < 0.001), from 51% among those aged 16-25 years
to 77% among the oldest aged 66-75 years (Table 1).
The prevalence of smoking was highest among women
(20%) compared to men (18%) (p = 0.001) overall and in
most age groups (Table 2), while being both ex-smokers
and non/never smokers were similarly common in men
and women. There were no major differences in the prev-
alence of smoking by age group, except in the age group
of 66-75 years, of which 14% were smokers.
Prevalence - asthma
The prevalence of physician-diagnosed asthma was 8.3%
(women 9.1%; men 7.4%, p < 0.001). Asthma prevalence
was 9.6% in 16-25 year old subjects, which increased to
10.2% in those aged 26-35 years, and then decreased sig-
Sweden with the city of Gothenburg and the region of West  Gothia Figure 1
Sweden with the city of Gothenburg and the region 
of West Gothia.R
e
s
p
i
r
a
t
o
r
y
 
R
e
s
e
a
r
c
h
 
2
0
0
9
,
 
1
0
:
9
4
h
t
t
p
:
/
/
r
e
s
p
i
r
a
t
o
r
y
-
r
e
s
e
a
r
c
h
.
c
o
m
/
c
o
n
t
e
n
t
/
1
0
/
1
/
9
4
P
a
g
e
 
4
 
o
f
 
1
1
(
p
a
g
e
 
n
u
m
b
e
r
 
n
o
t
 
f
o
r
 
c
i
t
a
t
i
o
n
 
p
u
r
p
o
s
e
s
)
Table 1: Study population by age, sex and area. 
Age (years) Sex Area
Study 
population
16-25 26-35 36-45 46-55 56-65 66-76 Men Women p-value West 
Gothia
Gothenburg p-value Total
Initial study 
sample
N 30000
Not possible to 
trace
N (%) 157 (2.3) 165 (2.8) 80 (1.4) 49 (1.0) 26 (0.5) 12 (0.4) 311 (2.0) 178 (1.2) < 0.001 175 (1.2) 314 (2.1) < 0.001 489 (1.6)
Deceased N (%) 1 (0.02) 1 (0.02) 1 (0.02) 3 (0.06) 2 (0.04) 9 (0.3) 11 (0.07) 6 (0.04) 0.225 9 (0.1) 8 (0.1) < 0.001 17 (0.06)
Moved N (%) 40 (0.7) 24 (0.4) 12 (0.2) 3 (0.06) 2 (0.04) 6 (0.2) 41 (0.3) 46 (0.3) 0.594 30 (0.2) 57 (0.4) 0.005 87 (0.3)
Not able due to 
disease or 
disability
N (%) 11 (0.2) 11 (0.2) 14 (0.2) 18 (0.4) 33 (0.7) 34 (1.2) 66 (0.4) 55 (0.4) 0.318 64 (0.4) 57 (0.4) 0.525 121 (0.4)
Other causes N (%) 11 (0.2) 14 (0.2) 9 (0.2) 13 (0.3) 9 (0.2) 12 (0.4) 37 (0.3) 31 (0.2) 0.544 32 (0.2) 36 (0.2) 0.716 68 (0.2)
Real study 
sample
N 5242 5653 5593 4947 4941 2842 14534 14684 14691 14527 29218
Did not want to 
participate or 
returned a blank 
questionnaire
N (%) 61 (1) 50 (1) 56 (1) 62 (1) 88 (2) 82 (3) 186 (1) 213 (2) 0.226 222 (2) 177 (1) 0.034 399 (1)
Non-responders N (%) 2577 
(49)
2484 
(44)
2247 
(40)
1660 
(34)
1194 
(24)
570 (20) 6158 (42) 4574 (31) < 0.001 5039 (34) 5693 (39) < 0.001 10732 
(37)
Responders N (%) 2604 
(51)
3119 
(55)
3290 
(59)
3225 
(65)
3659 
(74)
2190 
(77)
8190 
(56)
9897 (67) < 0.001 9430 (64) 8657 (60)  < 0.001 18087 
(62)
Difference (p-value) by sex and area.
Table 2: Smoking habits (%) by age and sex.
Age (years) Sex Area
Smoking 
status
16-25 years 26-35 years 36-45 years 46-55 years 56-65 years 66-76 years
Men Women Men Women Men Women Men Women Men Women Men Women All men All 
women
Gothenbu
rg
West 
Gothia
Non-
smokers
79.4 69.4 71.2 68.2 66.2 59.8 52 46.5 43.3 47.8 46.2 57.4 59 58 58 59
Ex-smoker 3.9 6.9 12.2 15.6 16.4 19.9 27.3 29.8 36.7 31.6 37.7 28.8 23 22 22 23
Smokers 15.8 23.4 16.2 15.9 16.9 19.7 20 23.2 19.4 19.9 15.7 13.3 18 20 20 17R
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Table 3: Prevalence (%) by age, sex and area. 
Age (years) Gender Area
Symptom or 
disease
16-25 26-35 36-45 46-55 56-65 66-75 test for 
trend
M W p-value Total Gothen-
burg
West 
Gothia
p-value
Ever asthma 11.2 12.2 10.2 8.5 8.2 7.6 < 0.001 8.7 10.5 < 0.001 9.7 9.9 9.5 0.330
Physician-
diagnosed 
asthma
9.6 10.2 8.4 7.2 7.4 7.1 < 0.001 7.4 9.1 < 0.001 8.3 8.4 8.3 0.759
Asthma 
medicine
9.3 8.9 8.3 8.3 8.2 8.9 0.293 6.8 10.1 < 0.001 8.6 8.7 8.5 0.780
Rhinitis 27.8 33.5 31.5 27.4 22.4 16.1 < 0.001 26.0 27.6 0.020 26.9 28.3 25.6 < 0.001
Attacks of 
SOB
9.3 9.9 9.8 9.3 9.0 10.0 0.764 7.5 11.2 < 0.001 9.5 9.9 9.1 0.066
Recurrent 
wheeze
5.0 5.4 6.3 7.8 7.9 8.8 < 0.001 6.8 6.9 0.976 6.8 7.2 6.5 0.056
Any wheeze 16.0 16.9 16.3 17.2 16.7 16.1 0.850 15.3 17.6 < 0.001 16.6 17.3 15.9 0.014
Wheeze with 
breathlessness
10.1 10.9 10.8 11.3 10.4 9.7 0.633 9.1 11.8 < 0.001 10.6 11.1 10.1 0.030
Wheeze 
without cold
8.6 9.9 8.9 10.2 9.7 9.8 0.137 8.9 10.1 0.008 9.5 10.1 9.0 0.012
Wheezing with 
breathlessness 
apart from 
cold
5.8 6.3 5.9 6.2 5.7 5.8 0.678 5.3 6.4 0.002 5.9 6.4 5.5 0.013
Longstanding 
cough
13.3 11.3 11.1 10.7 11.3 11.3 0.056 10.2 12.4 < 0.001 11.4 12.1 10.8 0.004
Sputum 
production
15.6 13.0 12.1 12.0 12.8 15.7 0.617 13.1 13.5 0.429 13.3 14.4 12.3 < 0.001
Chronic 
productive 
cough
4.0 5.0 5.4 6.7 6.8 9.0 < 0.001 6.1 6.1 1.000 6.1 6.4 5.7 0.043
Dyspnoea 3.5 3.2 4.5 6.4 9.9 12.9 < 0.001 4.8 8.1 < 0.001 6.6 6.7 6.5 0.611
Difference (p-value) by age, sex and area.Respiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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nificantly by increasing age to 7.1% in 66-75 year old sub-
jects (Table 3). Ever having asthma was reported by 9.7%
(women 10.5%; men 8.7%, p < 0.001) and the prevalence
of having either physician-diagnosed asthma or ever asthma
was 10.2%. The use of asthma medicines was reported by
6.8% of men and 10.1% of women (p < 0.001). Of those
reporting physician-diagnosed asthma, 70% reported
using asthma medication.
Active asthma (ever having asthma and having symptoms
or using asthma mediation) was detected in 6.9% of the
sample. Of these, 84.2% reported use of asthma medica-
tion, 73.0% attacks of shortness of breath, 39.1% any wheeze
and 74.1% recurrent wheeze. The number of symptoms
and/or use of asthma medicines among subjects with
active asthma are shown in Figure 2. Forty-six percent of
the 5.9% reporting wheezing with breathlessness apart from
cold had not reported they had ever asthma or physician-
diagnosed asthma, a result corresponding to 2.7% of the
participating study sample.
Prevalence - respiratory symptoms
The most common respiratory symptom reported was any
wheeze (16.6%), followed by sputum production (13.3%),
longstanding cough (11.4%) and attacks of shortness of breath
(9.5%). Recurrent wheeze was reported by 6.8% and chronic
productive cough by 6.1%, with both equally common in
men and women. Most symptoms common in asthma
were significantly more prevalent among women, while
bronchitic symptoms were equally common in men and
women. Ever asthma, physician-diagnosed asthma and use of
asthma medicines were equally common in the metropoli-
tan area of Gothenburg and the remaining part of West
Gothia, while most symptoms were slightly but signifi-
cantly more common in Gothenburg. Prevalence of symp-
toms by age, gender and domicile area is reported in Table
3.
Comparison with previous studies
When comparing the results of the current study with the
ECRHS study performed in 1990 [31], the prevalence of
most airway symptoms had decreased considerably and
significantly between 1990 and 2008. Specifically, any
wheeze had been reduced from 23% to 17% (p < 0.001),
sputum production from 21% to 15% (p < 0.001) and long-
standing cough from 18% to 12% (p < 0.001), while
reports of asthma indicate some increase asthma from 6%
to 8%, and a slightly increased use of asthma medicines
from 5% to 6% (Figure 3). The decrease in symptom prev-
alence was accompanied by a 50% reduction in smoking
prevalence from 42% to 21%.
Comparisons were also made with a study performed in
the former county of Southern Älvsborg in the southern
part of the region in 1994 [32]. While any wheeze
decreased from 18.2% to 15% (p < 0.001) and attacks of
shortness of breath did not change (7% vs. 8%), sputum pro-
duction increased from 9% to 11% (p = 0.015). All out-
comes relating to asthma increased significantly,
including ever asthma from 6% to 11% (p < 0.001), and
both physician-diagnosed asthma as well as use of asthma
medicines increased from 5% to 9% (p < 0.001). The prev-
alence of smoking decreased over these 14 years from
32% to 18% (p < 0.001).
Multivariate relationships - risk factors for asthma and 
symptoms
In the risk factor analyses using multiple logistic regres-
sion, the dependent variables include physician-diagnosed
asthma, attacks of shortness of breath, any wheeze, recurrent
wheeze  and  sputum production. For physician-diagnosed
asthma, rhinitis was the dominant risk factor yielding an
OR of 5.41 (95% CI 4.81-6.08) followed by family history
of asthma, OR 2.61 (2.31-2.94). Female sex was signifi-
cantly associated with physician-diagnosed asthma; OR
1.17 (1.05-1.32), as was ex-smoking; OR 1.34 (1.16-1.55)
while current smoking was borderline significant. Having
an age of 16-30 resulted in the highest risk of having
asthma (Table 4).
Compared with asthma, attacks of shortness of breath had a
similar risk factor pattern with slightly lower OR for rhin-
Prevalence of active asthma in relation to the number of  symptoms or use of asthma medicine Figure 2
Prevalence of active asthma in relation to the 
number of symptoms or use of asthma medicine.Respiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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itis and family history of asthma, but higher for female
sex, OR 1.46 (1.30-1.63). Furthermore, increasing age was
a significant risk factor for this symptom, as was both ex-
smoking and current smoking (Table 4).
Any wheeze was less associated with rhinitis, family history
of asthma and female sex than attacks of shortness of breath,
which was similarly associated with age but yielded an OR
of 3.37 (3.04-3.72) for current smoking. Recurrent wheeze
was more age dependent and more strongly associated
with current smoking, OR 3.88 (3.36-4.47) than any
wheeze, but was not dependent on sex. Moreover, sputum
production presented a risk factor pattern that was similar
with both any wheeze and recurrent wheeze although with
considerably lower odds ratios. Furthermore, living in the
metropolitan area of Gothenburg was also slightly associ-
ated with sputum production and yielded an OR of 1.17
(1.06-1.28) (Table 4).
The most age dependent symptom was dyspnoea, for
which age 61-75 yielded an OR of 4.60 (3.73-5.67), fol-
lowed by chronic productive cough, OR 2.25 (1.83-2.75)
and recurrent wheeze, OR 2.21 (1.82-2.69), both in the
same age group.
Discussion
This study presents the most updated information on the
current prevalence of asthma and respiratory symptoms in
northern Europe. Furthermore, the study allows for anal-
yses of change in prevalence over eighteen years, for which
there is no published recent evaluation using similar
methods. Importantly, the overall message of this study is
that the previously demonstrated increase in prevalence of
asthma has levelled off in the region. Furthermore, most
respiratory symptoms have significantly decreased in
prevalence.
The prevalence of physician-diagnosed asthma in this
study was estimated to be 8.3% and was greater in women
than men. The current questionnaire study used nearly
identical questions to the ones used in studies performed
in 1996 in Finland, Estonia and Sweden (the FinEsS Stud-
ies), as well as in other studies performed in three differ-
ent regions of Sweden, the capital Stockholm, the county
of Norrbotten and the city of Örebro [10,24-26]. In both
Örebro and Stockholm, the prevalence of asthma was esti-
mated to be 8%, while it was 10% in Norrbotten [10,24-
26]. Thus, our study together with the previous studies
strongly support the notion that the prevalence of asthma
in Sweden is currently between 8-10%, with minor
regional variation, with no further increase observed since
the late 1990s.
Comparison of the prevalence of respiratory symptoms using identical questions in the ECRHS Study (1990) and in the current  study (2008) among 20-44 year old subjects living in the area of Hisingen, Gothenburg (* p < 0.05, ** p < 0.01, ***p < 0.001) Figure 3
Comparison of the prevalence of respiratory symptoms using identical questions in the ECRHS Study (1990) 
and in the current study (2008) among 20-44 year old subjects living in the area of Hisingen, Gothenburg (* p < 
0.05, ** p < 0.01, ***p < 0.001).Respiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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When comparing our results with the Gothenburg part of
the ECRHS performed eighteen years before our study, the
reported prevalence of asthma had increased from 6% to
8% in the same area of Gothenburg, the Hisingen Island
[31]. However, this comparison must be judged with
some reservation, because the difference is modest and
the questions about asthma were not exactly identical. An
increase of a similar magnitude was also observed in the
southern part of our study area, the former county of
Southern Älvsborg [32], but in this case using identical
questions about asthma. Whether this increase after early
1990s reflects a real increase in asthma prevalence cannot
be firmly verified, as the symptoms of asthma in the cur-
rently investigated individuals have been reduced. Thus,
our findings suggest that a greater proportion of mildly
symptomatic asthmatics today are diagnosed as having
asthma, since the prevalence of active asthma was only
6.9% in the current study, and about half of these individ-
uals used either asthma medication or had only one or
two symptoms common in asthma (Figure 2). Those diag-
nosed with asthma in the 1980s and 1990s had clearly
more symptoms of asthma than found in the current
study and other recent studies [23,33]. In addition, a
greater proportion of asthmatics utilised asthma medica-
tion in the 1980s and the early 1990s compared to the
individuals with diagnosed asthma in our study. These
two findings together argue that a greater proportion of
patients with mild asthma and asthma like symptoms
have received the diagnosis of asthma compared to the
early 1990s. This conclusion is further supported by the
studies of the incidence of asthma in northern Sweden
from 1986 to 1996, which discovered that approximately
half of the cases were as a result of better detection of
asthma and of increased diagnostic activity within the
medical community [28]. Therefore, the slight increase in
doctor's diagnosis of asthma comparing our study with
the two studies in 1990 and 1994 may be explained by an
increased diagnosis of asthma rather than a true increase
in prevalence.
In contrast to the decrease in prevalence of respiratory
symptoms, our study demonstrated a clear increase in the
prevalence of allergic rhinitis in the area of Hisingen com-
pared to the 1990 ECRHS study results [31]. As allergic
rhinitis is closely associated with allergic sensitisation,
this marked increase might reflect an increase in allergy
sensitisation in the area. While there is no recent data
about the prevalence of allergic sensitisation in Sweden,
ongoing clinical examinations of the current cohort will
provide such information in the next few years. As rhinitis
is a risk factor for the development of asthma, it cannot be
excluded that the prevalence of asthma may again increase
in Sweden in the future.
The argument that a plateau in asthma prevalence has
been reached after the late 1990s is supported by the
decrease or lack of increase of the prevalence of respiratory
symptoms in different age groups in the current study.
Comparing our results with the prevalence of symptoms
in the 1990 ECRHS study in Gothenburg [31], almost all
Table 4: Risk factors for asthma and respiratory symptoms by multiple logistic regression analysis. 
Independant variables Dependant variables OR (95% CI)
Variables* Categories Physician 
diagnosed asthma
Attacks of 
shortness of 
breath
Any wheeze Recurrent 
wheeze
Sputum 
production
Family history of 
asthma
Yes 2.61 (2.31-2.94) 2.44 (2.17-2.74) 2.01 (1.82-2.21) 2.35 (2.05-2.68) 1.67 (1.50-1.86)
Rhinitis Yes 5.41 (4.81-6.08) 4.96 (4.44-5.53) 2.94 (2.69-3.21) 2.72 (2.39-3.09) 2.02 (1.83-2.22)
Smoking Ex-smokers 1.34 (1.16-1.55) 1.29 (1.13-1.48) 1.39 (1.24-1.55) 1.35 (1.14-1.59) 1.23 (1.09-1.39)
Smokers 1.14 (0.98-1.33) 1.81 (1.58-2.07) 3.37 (3.04-3.72) 3.88 (3.36-4.47) 2.62 (2.36-2.92)
Age 31-45 0.84 (0.72-0.98) 1.07 (0.92-1.24) 1.01 (0.90-1.14) 1.28 (1.05-1.55) 0.81 (0.71-0.92)
46-60 0.74 (0.63-0.87) 1.06 (0.91-1.25) 1.06 (0.94-1.20) 1.71 (1.42-2.07) 0.81 (0.71-0.92)
61-75 0.90 (0.75-1.07) 1.32 (1.12-1.56) 1.20 (1.05-1.37) 2.21 (1.82-2.69) 1.10 (0.96-1.26)
Region Gothenburg 0.95 (0.85-1.06) 1.04 (0.93-1.16) 1.06 (0.97-1.15) 1.12 (0.99-1.27) 1.17 (1.06-1.28)
Sex Women 1.17 (1.05-1.32) 1.46 (1.30-1.63) 1.10 (1.01-1.20) 0.91 (0.80-1.03) 0.98 (0.89-1.07)
Risks in odds ratios (OR) with 95% confidence intervals (95% CI).
* As compared to no family history of asthma, no rhinitis, non-smokers, 16-30 years of age, living in West Gothia and men respectively.Respiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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respiratory symptoms decreased significantly (Figure 3).
Symptoms that may be related to smoking, such as any
wheeze,  sputum production and  longstanding cough were
reduced, but symptoms that are closely related to asthma
including wheezing with breathlessness also decreased mark-
edly. A clear decrease in the prevalence of wheezing was
also observed in southern Älvsborg. No major changes
were found regarding other respiratory symptoms, which
may in part be explained by some differences in the ques-
tionnaires [32].
The decrease in prevalence of respiratory symptoms in the
area of Hisingen in Gothenburg may have several explana-
tions. Firstly, a major decrease in smoking prevalence was
observed. Furthermore, a change in socio-economic status
composition has been observed in parts of the area, from
predominantly working class to middle class. In addition,
this area contained pollution emitting industries until
approximately the 1980s. Thus, changes in smoking hab-
its, industrial structure and socio-economic status compo-
sition are all parallel with the decrease observed in
respiratory symptoms. It should also be considered that
the reduction in respiratory symptoms may partly be due
to patients with airway diseases now having access to
more efficient medications.
The demonstrated risk factor patterns for asthma and
symptoms in the current study confirm findings from pre-
vious studies [23,24,26,33]. Rhinitis was strongly associ-
ated with asthma, and the magnitude of the odds ratio
was similar to that previously reported in asthma studies
of Swedish adults [24]. As the study design was cross-sec-
tional, the results only verify an association and cannot
contribute to the discussion of either cause or conse-
quence. A family history of asthma was significantly
related to both asthma and respiratory symptoms, but
tended to be somewhat less related to asthma than found
previously [24,33], a fact that may be explained by a
broader labelling of the term asthma by the medical com-
munity, and the inclusion of patients with milder disease
in this category. In agreement with previous studies,
female sex and ex-smoking was closely associated with
asthma, while current smoking was only associated with
asthma with borderline significance [24,26,33].
Regarding age, the multivariate analysis verified that
young adults are at highest risk of having a diagnosis of
asthma. Interestingly, studies performed in the 1990s
found asthma to be most common in adolescents and
young adults [24], closely related to a high incidence in
children and teenagers [34,35]. In the current study, the
prevalence was highest in the age group of 26-35 year olds
(physician-diagnosed asthma 10.2%), while it was lower
in the age group of 16-25 year olds, arguing against a fur-
ther increase in prevalence of asthma in the lower age
group. The current findings, together with findings from
several studies presented in the last decades, argue that the
continued increase in asthma prevalence that has been
observed over half a century is now over.
All respiratory symptoms were significantly associated
with smoking. The symptoms most closely related to
smoking were any and recurrent wheeze, cough and spu-
tum production. These findings are similar to reports
from several Scandinavian studies [23,26,36]. Chronic
respiratory symptoms increased with increasing age, a
relationship that was confirmed by the multivariate anal-
ysis. However, it was observed that symptoms were less
age-dependent compared with previous Swedish studies
[21,23,27]. High age (61-75 years) was poorly related to
most respiratory symptoms with odds ratios of 1.00 to
1.32, and most of these symptoms did not significantly
relate to age.
The differences in prevalence in asthma and respiratory
symptoms between the metropolitan area of Gothenburg
and the non-metropolitan area were strikingly small. All
asthma-associated variables were equally common in the
two samples, while the prevalence of most symptoms was
only slightly, but significantly, more common in the city
of Gothenburg. Thus, in the multivariate analyses, the
area of domicile, i.e. living in Gothenburg, was a signifi-
cant risk factor only for sputum production. These results
may reflect an improvement in the levels of outdoor air
pollution in the metropolitan areas in Sweden [37].
This study provides conclusive results for several reasons.
The large sample size and the use of well validated ques-
tionnaires contribute to high internal validity of the
results. As identical questions have been used in several
previous studies, many opportunities for comparisons
were available, and can contribute to further analyses.
Therefore, the external validity can be judged as high,
partly because this study can be utilised for future compar-
isons. The response rate was slightly lower than in earlier
Swedish and Nordic studies [23-29]. However, in a study
of non-responders, no important bias was detected
between early and late responders [30]. The alternative of
answering over the internet was utilised by surprisingly
few individuals, but could still be a more efficient way of
working in the future, especially with younger genera-
tions. Postal questionnaires always have one key weak-
ness in that they can never provide evidence for any direct
causal reasons or mechanistic information in any disease.
Furthermore, the cross-sectional design itself makes dis-
cussion of cause or consequence, as well as detected asso-
ciations, less convincing.
In conclusion, our study provides new and unique evi-
dence that the previous increase in asthma prevalenceRespiratory Research 2009, 10:94 http://respiratory-research.com/content/10/1/94
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over the last 10-15 years in West Sweden has now levelled
off. Asthma is still highly prevalent, with 8.3% of the pop-
ulation being affected, which makes it one of the most
common diseases in Sweden. Furthermore, asthma can
still be lethal, and the incidence of asthma mortality in
children and young adults has only partly decreased in the
last decade [38].
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